All News Top News Aug 21, 2019 Fremanezumab Data in The Lancet Demonstrate Clinically Meaningful Reduction in Monthly Migraine Days Versus Placebo for Patients with Difficult-To-Treat Migraine Learn More Share Top News Aug 20, 2019 Teva Announces Availability of a Generic Equivalent of EpiPen Jr® (epinephrine injection, USP) Auto-Injector, 0.15 mg in the United States Learn More Share Top News Aug 7, 2019 Teva Announces CFO Leadership Transition Learn More Share Top News Aug 7, 2019 Teva Reports Second Quarter 2019 Financial Results Learn More Share Top News Jul 15, 2019 Teva Announces FDA Approval of AirDuo® Digihaler™ (fluticasone propionate 113 mcg and salmeterol 14 mcg) Inhalation Powder Learn More Share
Top News Aug 21, 2019 Fremanezumab Data in The Lancet Demonstrate Clinically Meaningful Reduction in Monthly Migraine Days Versus Placebo for Patients with Difficult-To-Treat Migraine Learn More
Top News Aug 20, 2019 Teva Announces Availability of a Generic Equivalent of EpiPen Jr® (epinephrine injection, USP) Auto-Injector, 0.15 mg in the United States Learn More
Top News Jul 15, 2019 Teva Announces FDA Approval of AirDuo® Digihaler™ (fluticasone propionate 113 mcg and salmeterol 14 mcg) Inhalation Powder Learn More